CEVOSTAMAB: 64 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
64
Total FAERS Reports
12 (18.8%)
Deaths Reported
50
Hospitalizations
64
As Primary/Secondary Suspect
5
Life-Threatening
First Report: 20190928 · Latest Report: 20240730
What Are the Most Common CEVOSTAMAB Side Effects?
#1 Most Reported
Cytokine release syndrome
18 reports (28.1%)
#2 Most Reported
Dyspnoea
7 reports (10.9%)
#3 Most Reported
Pyrexia
6 reports (9.4%)
All CEVOSTAMAB Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Cytokine release syndrome | 18 | 28.1% | 4 | 15 |
| Dyspnoea | 7 | 10.9% | 0 | 5 |
| Bronchopulmonary aspergillosis | 6 | 9.4% | 0 | 4 |
| Dizziness | 6 | 9.4% | 0 | 4 |
| Drug interaction | 6 | 9.4% | 0 | 4 |
| Nausea | 6 | 9.4% | 0 | 4 |
| Plasma cell myeloma | 6 | 9.4% | 4 | 4 |
| Pneumonia | 6 | 9.4% | 1 | 6 |
| Pyrexia | 6 | 9.4% | 0 | 4 |
| Febrile neutropenia | 5 | 7.8% | 0 | 4 |
Who Reports CEVOSTAMAB Side Effects? Age & Gender Data
Gender: 40.0% female, 60.0% male. Average age: 66.2 years. Most reports from: US. View detailed demographics →
Is CEVOSTAMAB Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2019 | 1 | 1 | 0 |
| 2020 | 5 | 3 | 4 |
| 2021 | 4 | 1 | 3 |
| 2022 | 29 | 6 | 24 |
| 2023 | 13 | 1 | 13 |
| 2024 | 3 | 0 | 1 |
What Is CEVOSTAMAB Used For?
| Indication | Reports |
|---|---|
| Plasma cell myeloma | 52 |
| Plasma cell myeloma refractory | 7 |
Official FDA Label for CEVOSTAMAB
Official prescribing information from the FDA-approved drug label.